← Leaderboards
Jun-Li Luo
Scripps Research Institute, The
$4,397,191
Attributed
$4,397,191
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $628.2K · FY2011–20$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,397,191 · 3
By mechanism
R01$4,199,191 · 2
R21$198,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Scripps Research Institute, The
Same institution · by research overlap
- Douglas A Lauffenburger$27,665,222
- Kendall W Nettles$12,009,144
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsBaseMalignant Neoplasm Of ProstateGrowthNovel TherapeuticsHormone Refractory Prostate CancerTumor GrowthRefractoryHormonesMalignant NeoplasmsAdenocarcinomaTumorCancer CellPharmaceutical PreparationsMouse ModelCarcinomaProstatic Intraepithelial NeoplasiasCastration Resistant Prostate CancerPathway InteractionsB-LymphocytesNuclearPhosphotransferasesInhibitor/AntagonistCell Proliferation
Grant awards (11)
Development of cancer therapeutic TBK1/IKKi dual inhibitors$439,200
R01 · FY2020 · CA · contact PI
Development of cancer therapeutic TBK1/IKKi dual inhibitors$426,023
R01 · FY2019 · CA · contact PI
Development of cancer therapeutic TBK1/IKKi dual inhibitors$439,200
R01 · FY2018 · CA · contact PI
Development of cancer therapeutic TBK1/IKKi dual inhibitors$439,200
R01 · FY2017 · CA · contact PI
Development of cancer therapeutic TBK1/IKKi dual inhibitors$439,200
R01 · FY2016 · CA · contact PI
Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.$405,676
R01 · FY2015 · CA · contact PI
Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.$393,505
R01 · FY2014 · CA · contact PI
Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.$381,335
R01 · FY2013 · CA · contact PI
Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.$405,676
R01 · FY2012 · CA · contact PI
Immune-inflammatory signaling and hormone-refractory prostate cancer evolution.$430,176
R01 · FY2011 · CA · contact PI
Assay Development for Screening of Specific IKKalpha Kinase Inhibitors$198,000
R21 · FY2011 · NS · contact PI